Users must complete a health assessment to ensure they qualify medically for the weight loss medications
Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C (2001) Knee osteoarthritis and obesity
Mucosal administration pathways covering nasal, oral and buccal routes possess prominent merits, including convenient operation, pain-free injection and favorable initial patient compliance, which endow them with bright prospects for chronic disease treatment
This modification slows the drugs breakdown by enzymes, extending how long it stays active in the body
Contraindications to GLP-1 drug use include severe kidney disease, pancreatitis, medullary thyroid cancer and pregnancy